ArticleKidney cancer (Clifton, Va.)2019

Everolimus Exposure as a Predictor of Toxicity in Renal Cell Cancer Patients in the Adjuvant Setting: Results of a Pharmacokinetic Analysis for SWOG S0931 (EVEREST), a Phase III Study (NCT01120249).

Timothy W Synold et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.